Technology Strategy Board Invests over £90 Million in Healthcare Projects

August 14, 2013 – 1:52 pm

The UK Technology Strategy Board has announced a multi-million dollar investment in healthcare projects. The funding includes £25.9 million from the latest round of the Biomedical Catalyst, £38 million for a National Biologics Industry Innovation Centre in Darlington and £29.3 million investment through three competitions for healthcare innovation funding.

The Biomedical Catalyst launched in 2011 and funds small and medium-sized businesses and researchers looking to work individually or together to develop solutions to healthcare challenges. Three categories of grant are available: feasibility award, early-stage award and late-stage award. Round 4 is now open for applications for early and late-stage awards.

In addition to the Biomedical Catalyst funding, the TSB has awarded £25.9 million in three healthcare funding competitions related to patient-specific approaches to healthcare, diagnostic tests for tuberculosis and regenerative medicine and cell therapy.

The National Biologics Industry Innovation Centre in Darlington, which received a £38 million investment, will be used to fund manufacturing of biological medicines such as antibodies and vaccines.

Details of the programs that received funding can be found on TSB’s website.

Related Posts Plugin for WordPress, Blogger... Camilla Andersson
Bookmark and Share

Post a Comment